These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 38534705)

  • 21. Multidrug-resistant Cutibacterium avidum isolated from patients with acne vulgaris and other infections.
    Koizumi J; Nakase K; Hayashi N; Nasu Y; Hirai Y; Nakaminami H
    J Glob Antimicrob Resist; 2022 Mar; 28():151-157. PubMed ID: 35017069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilizing the photodynamic properties of curcumin to disrupt biofilms in Cutibacterium acnes: A promising approach for treating acne.
    Zheng N; Xie Y; Zhou M; Liu Y; Xu H; Zeng R; Wan C; Li M
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103928. PubMed ID: 38070633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The versatility of azelaic acid in dermatology.
    Searle T; Ali FR; Al-Niaimi F
    J Dermatolog Treat; 2022 Mar; 33(2):722-732. PubMed ID: 32730109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topically administered clindamycin in the treatment of acne vulgaris and other dermatologic disorders.
    Rosen T; Waisman M
    Pharmacotherapy; 1981; 1(3):201-5. PubMed ID: 6242711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiomes in Acne Vulgaris and Their Susceptibility to Antibiotics in Indonesia: A Systematic Review and Meta-Analysis.
    Legiawati L; Halim PA; Fitriani M; Hikmahrachim HG; Lim HW
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction.
    Leyden J
    Cutis; 2001 Feb; 67(2 Suppl):5-7. PubMed ID: 11236213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic-resistant acne: lessons from Europe.
    Ross JI; Snelling AM; Carnegie E; Coates P; Cunliffe WJ; Bettoli V; Tosti G; Katsambas A; Galvan Peréz Del Pulgar JI; Rollman O; Török L; Eady EA; Cove JH
    Br J Dermatol; 2003 Mar; 148(3):467-78. PubMed ID: 12653738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life.
    Greydanus DE; Azmeh R; Cabral MD; Dickson CA; Patel DR
    Dis Mon; 2021 Apr; 67(4):101103. PubMed ID: 33041056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic sensitivity of Propionibacterium acnes isolates from patients with acne vulgaris in a tertiary dermatological referral centre in Singapore.
    Tan HH; Goh CL; Yeo MG; Tan ML
    Ann Acad Med Singap; 2001 Jan; 30(1):22-5. PubMed ID: 11242619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
    Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
    Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic Susceptibility of Cutibacterium acnes Strains Isolated from Israeli Acne Patients.
    Sheffer-Levi S; Rimon A; Lerer V; Shlomov T; Coppenhagen-Glazer S; Rakov C; Zeiter T; Nir-Paz R; Hazan R; Molho-Pessach V
    Acta Derm Venereol; 2020 Oct; 100(17):adv00295. PubMed ID: 33021324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
    Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic Treatment of Hidradenitis Suppurativa.
    Bettoli V; Join-Lambert O; Nassif A
    Dermatol Clin; 2016 Jan; 34(1):81-9. PubMed ID: 26617361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased prevalence of doxycycline low-susceptible Cutibacterium acnes isolated from acne patients in Japan caused by antimicrobial use and diversification of tetracycline resistance factors.
    Aoki S; Nakase K; Hayashi N; Nakaminami H; Noguchi N
    J Dermatol; 2021 Sep; 48(9):1365-1371. PubMed ID: 33998707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics.
    Iinuma K; Noguchi N; Nakaminami H; Sasatsu M; Nishijima S; Tsuboi I
    Clin Cosmet Investig Dermatol; 2011; 4():161-5. PubMed ID: 22087070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic antibiotic therapy of acne vulgaris.
    Ochsendorf F
    J Dtsch Dermatol Ges; 2006 Oct; 4(10):828-41. PubMed ID: 17010172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transferable Multidrug-Resistance Plasmid Carrying a Novel Macrolide-Clindamycin Resistance Gene,
    Aoki S; Nakase K; Nakaminami H; Wajima T; Hayashi N; Noguchi N
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.